Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline - Talbot, K; Wang, H Y; Kazi, H (J Clin Invest, 2012)
et al.